Cheri L Graham

Statistics

Publications

Citations

218

H-Index

Active since

2003

Affiliations

Gynecologic Oncology Associates(Current)

The University of Texas MD Anderson Cancer Center

Hoag Memorial Hospital Presbyterian

Cheri L Graham is an author at Gynecologic Oncology Associates specializing in malignant neoplasms, chemotherapy, and gynecologic cancer pharmacotherapy.

Publications per year

2003–2009

Publications

A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer

John P. Micha, Bram H. Goldstein, Mark A. Rettenmaier et al. · International Journal of Gynecological Cancer · 2007 · 106 citations

Medicine, Gynecology, Oncology +17

Three-consecutive-day topotecan is an active regimen for recurrent epithelial ovarian cancer☆

John V. Brown, William A. Peters, Mark A. Rettenmaier et al. · Gynecologic Oncology · 2003 · 41 citations

Medicine, Oncology, Pharmacology +15

Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer

John P. Micha, Bram H. Goldstein, Julie A. Mattison et al. · Gynecologic Oncology · 2004 · 23 citations

Medicine, Gynecology, Oncology +13

Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer

John P. Micha, Bram H. Goldstein, Mark A. Rettenmaier et al. · Gynecologic Oncology · 2004 · 21 citations

Medicine, Gynecology, Oncology +14

Improved Survival with Single-Agent Paclitaxel Consolidation/Maintenance Therapy in Advanced Ovarian Carcinoma

John P. Micha, Bram H. Goldstein, Cheri L Graham et al. · Oncology · 2006 · 16 citations

Medicine, Oncology, Pharmacology +15

1–5 of 6